INTRODUCTION
The occurrence of multiple virus infections in the same patient is, intuitively, not surprising and is not an unusual finding. Multiple virus infections associated with primary or secondary immunodeficiencies are relatively common. A latent infection, such as that following a primary infection with a human herpesvirus, in conjunction with other latent infections or with an acute infection with another virus also defines categories of mixed viral infections. More perplexing is the meaning of mixed, acute viral infections that occur at the same site in immunocompetent patients and involve viruses with similar expressions of disease. The incidence of such mixed infections, their clinical importance, and whether they warrant particular diagnostic or therapeutic considerations are unresolved questions. To focus on these questions, viruses of the respiratory tract were emphasized. Although multiple infections of the gastrointestinal tract are well recognized (3, 4, 72, 113) , the methods of diagnosis and knowledge of pathogenesis are limited compared with those for the common respiratory viruses. The ability of viruses to be immunosuppressive and thereby affect the host relative to other viral infections is also well recognized (90) but was not considered in this review.
Respiratory virus infections are the most numerous of acute viral infections. Several viruses that cause respiratory diseases circulate concurrently in the autumn, winter, and early spring (7, 14, (29) (30) (31) . There is a tendency, however, for epidemic outbreaks of respiratory viruses not to occur simultaneously in a given population (28, 30, 31 (66) . Most of the early virus studies were oriented to associating clinical findings with particular viruses with the goal of establishing viral etiologies for the diseases (23, 39, 41, 46, 73, 75) . The majority of the investigations employed serology as well as virus isolation. For example, Parrott et al. reported that 30% of patients with respiratory syncytial virus (RSV) also had serological evidence of another simultaneous viral infection (73) . A similar study of 667 cases of respiratory disease noted a 5% dual infection rate as discerned serologically by rises in antibody titer; of 34 patients studied by virus isolation, 4 (11%) yielded two different viruses (39) . In looking for an association of rhinovirus infection with lower respiratory disease, one report presented serological evidence showing that 38% of the study population had a concomitant viral infection (76) (35) .
A single mixed infection of RSV and influenza A was reported in a concurrent outbreak of RSV and influenza in a nursing facility for the elderly; the patient developed pneumonia as did five patients with influenza only (56). A report of nine dual isolations of RSV and influenza A virus noted that there was no unusual severity of disease seen in the patients with dual infections; the same degree of illness could be seen in infections with either virus alone (33 (101) . Three of the four RSV-adenovirus patients died of respiratory failure. Importantly, all four of the patients had serious underlying problems that may have enhanced the likelihood of severe complications from the dual infections. In comparison, adenovirus was associated with 6 of 20 fatal cases reported in a 3-year survey of acute lower respiratory disease in 805 children. Three of the cases involved a mixed adenovirus-bacterial infection, and three were cases of adenovirus alone; both categories of infection occurred in patients with underlying conditions (6) . Considering these reports together, the relative threat of an adenovirus-mixed viral infection in an immunocompetent subject can not be discerned.
A retrospective study reported that 7.6% of 666 specimens with RSV (detected by isolation and/or DIF) also contained another virus; six additional dual infections not involving RSV were also noted. No significant difference in the severity of disease was seen, however, in a case control study of patients with RSV alone versus patients with RSV and another virus (93) . A prospective study involving 1,246 healthy infants also found no difference in the severity of disease in cases of mixed infection versus cases of RSV infection alone (82) . The latter study concluded that when RSV is detected in previously healthy infants, there is no clinical reason to search for other concomitant viral infections.
Studies of respiratory viral infections in developing countries also reported mixed viral infections (13, 26, 43, 70, 77, 79) . The incidence (<10%) was comparable to that reported in studies from industrialized countries (discussed below). Nor was there any indication of increased severity of disease. Rather, the role of mixed viral and bacterial infections was emphasized.
In summary, evidence for an association of mixed infections with increased severity of disease was not forthcoming. The primary intent of the majority of the studies was to associate agents with clinical syndromes relative to age and sex of the patients. In most instances, little more than anecdotal experiences with mixed infections were provided. Much of the data were derived from serological studies with few dual organism isolations reported. There were few instances of observations of clinical severity, and where noted, the reports did not indicate any increased severity that might be attributed to mixed infections.
MIXED VIRAL INFECTIONS IN IMMUNODEFICIENT PATIENTS
The virus-host relationship changes in the immunodeficient patient. Viruses that are normally latent in the immunocompetent host may reactivate and cause acute disease in the immunodeficient host; viral infections that are normally suppressed by the immune system may become chronic infections; and generally, the severity of disease resulting from a viral infection is likely to be greater in immunodeficient patients.
In a study of children with acute lymphoblastic leukemia, 20 of 99 (20%) patients had multiple viruses isolated from the same specimen (5); significantly, only 20 of 796 (2.5%) control patients (no malignant disease or immunosuppressive therapy) had similar mixed infections (5, 12) . When HSV was excluded, only three mixed infections were identified in healthy children. However, 17 mixed infections were identified in the leukemic (47) .
There was an indication of increased incidence of mixed infections in immunocompromised patients. The severity of respiratory disease in the patients with mixed infections, however, appeared comparable to that of single infections in patients with similar underlying diseases. The increased incidence may be attributable to the underlying condition of the patients. Immunocompromised patients excrete virus longer than immunocompetent patients (12, 21, 34, 47) . Latent viruses, such as HSVs and CMV, are commonly reactivated and may produce chronic infections (40, 108, 109) . Adenovirus infections also become prolonged and may result in serious disease (54, 116 (58) and enzyme immunoassay (EIA) (8, 16, 85, 86, 114) . More recently, the shell vial technique, which was originally described for the rapid identification of CMV (27) , has been used for the diagnosis of respiratory viruses (18, 49, 57, 69, 78, 89 (94) , and one study observed greater than 35% mixed infections in patients with viral infections (112) ; the total number of positive specimens in these studies was small, 21 and 17, respectively. The latter study was conducted during a simultaneous outbreak of parainfluenza and influenza.
Composition of mixed infections. Two hundred fifty-one mixed infections were identified in the literature reviewed (Table 2) (Table 3 ). The identification of other viruses was possible because multiple diagnostic methods were used in the studies, primarily isolation in cell culture or DIF. If the additional methods were not employed, the other viruses would not have been detected. This analysis demonstrated the need for a comprehensive strategy to identify both the mixed infections and, more importantly, the viruses present in specimens that would be considered negative if only one virus was targeted for diagno-S1S.
DAGNOSTIC CONSIDERATIONS
This review has focused on multiple viruses that are identified in the same clinical specimen. Simultaneous viral infections, however, often occur in different body sites in the immunocompromised patient. Both categories of mixed infections require the necessary laboratory resources to effect a comprehensive diagnosis. Virus isolation in cell cultures, identification of antigen directly in specimens, and centrifugation culture (shell vial technique) are the common methods that are most applicable to the problem.
Diagnostic Strategies
Strategies for the rapid diagnosis of multiple viral infections, whether from the same specimen or from specimens originating from different anatomic sites, must take into account both feasibility and cost; a major component of cost is hands-on time. The problem of diagnosis of multiple virus infections with cell cultures was addressed by Hsuing over 25 years ago (44) . A single cell culture is rarely useful for the identification of multiple viruses (Fig. 1) In the studies reporting >5% mixed infections, viruses were detected by isolation in cell culture, cell culture and DIF, or cell culture and EIA (Table 1) . Mixed infections were found in only two of seven studies in which the shell vial technique was used for identification of respiratory viruses. In these studies, the mixed infection rate was 1% (57) and 3% (78) . Additional experience is needed to fully evaluate the shell vial technique and its potential for detecting multiple viruses. DIF permits rapid diagnosis of multiple viruses in the same specimen. Cells obtained from a nasopharyngeal wash or aspirate, bronchial lavage, or lesion may be apportioned to numerous circumscribed wells on glass slides and stained by IF for as many viruses as the availability of cells and reagents permits (81, 106) . The viruses present are thereby identified in their natural host cell(s). Preventing the interaction of two or more viruses in a cell culture eliminates the possibility of interference or interferon production, either of which could compromise a diagnosis. Currently, DIF provides the optimum requirements for rapid and cost-effective analysis of multiple infections. Good monoclonal antibodies for the common viral pathogens and accompanying anti-immunoglobulin conjugates are available commercially, and the initial investment in a fluorescence microscope is modest.
The available EIA tests are targeted for a few important agents but are not available commercially as panels for differential diagnosis. EIA tests for most viruses, however, can be constructed in the laboratory, and comprehensive panels may be assembled. The general experience suggests that to account for their variable sensitivities and specificities EIA tests should be supported by virus isolation in cell cultures and/or DIF (36, 37, 49, 74, 94, 95, 97, 107) .
Future Prospects
An expanded use of cell cultures for diagnosis will require the identification of novel cell lines with enhanced abilities to support the replication of common viral pathogens and noncultivable viruses. Genetically engineered cell lines, such as 293 cells for adenoviruses 40 and 41 (96) , could be developed for use as centrifugation cultures (shell vials) to provide comprehensive and rapid diagnosis of the common and fastidious agents.
Recent presentations have reported a rapid immunofluorescence adaptation to DIF that permits a diagnosis in 20 min, a time comparable to that of the rapid EIA tests (64, 100) . Otherwise, DIF seems to have reached its limit of performance and remains very dependent on the quality of specimen collected and the acquired skill of the laboratory staff.
The newest adaptations to EIA have resulted in tests that produce results in 20 min (95, 105, 107 (17, 51, 83) .
There is evidence that dual infections of single cells occur in patients. CMV and HIV-1 were shown to coinfect brain cells (67) and retinal cells in patients with AIDS (88) . In the absence of CMV, the HIV-1-infected cells within the neural retina were not associated with inflammation or necrosis (88) . The (Fig. 2) .
